Tuesday, 6 December 2022

Key Research Articles


Billion-Dollar Biotransformations: On the Metabolism of Ozanimod | https://t.co/Q645d0Qcyn The fascinating metabolism of ozanimod, a likely megablockbuster drug for UC and MS, nearly derailed its approval. We explore the technical details here. Source: drughuntersite

No comments: